Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

COSCIENS Biopharma Inc T.AEZ


Primary Symbol: T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Post by prophetoffactzon Jul 16, 2024 2:49pm
129 Views
Post# 36135290

Name & symbol change

Name & symbol changePerplexity Ai:

Based on the information provided in the search results, the time between a company announcing a name and symbol change and it taking effect on the TSX and NASDAQ can vary, but generally occurs within a few days to a couple of weeks. Here are the specific details for each exchange:
For the Toronto Stock Exchange (TSX):
  1. A listed issuer must notify the TSX as soon as possible after the decision to change the name has been made.
  2. The company's securities will typically begin trading under the new name at the opening of business two or three trading days after the Exchange accepts the name change.
For NASDAQ:
  1. Companies are required to notify NASDAQ of a name change or security title change no later than 10 calendar days before the change becomes effective.
It's important to note that the exact timing can depend on various factors, including the completion of necessary paperwork and regulatory approvals. Companies may announce the change well in advance of the effective date, as seen in the example of Aquarius AI, which announced its name and symbol change on March 20, 2023, with an effective date of March 27, 2023.In general, once a company announces a name and symbol change, investors can expect the change to take effect within a few business days to two weeks, depending on the specific exchange requirements and the company's readiness to implement the change.
<< Previous
Bullboard Posts
Next >>